Advertisements

Fungiderm 1%

Quick links to important sections

Fungiderm 1%

Advertisements
Advertisements

Method of action: Antifungal Broad Spectrum

Treatment option: Hyperhidrosis

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Fungiderm 1%

Quick Facts

Property Description
Active ingredient Bifonazole (INN)
Form Cream (1% concentration)
Pharmacological class Azole Antifungal (Substituted Imidazole)
Route of administration Topical (Skin surface)
Origin Synthetic

Fungiderm 1%: Definition and Pharmacological Classification

Fungiderm 1% is a topical pharmaceutical preparation intended for the management of fungal skin conditions, with the synthetic compound Bifonazole serving as its sole active ingredient. This drug is formally classified within the Azole Antifungal group, recognized specifically as a substituted imidazole derivative. The World Health Organization (WHO) assigns Bifonazole the Anatomical Therapeutic Chemical (ATC) code D01AC10, which confirms its established role as an antimycotic agent for dermatological applications. Bifonazole is recognized for its broad-spectrum efficacy against a diverse range of common skin fungi.

Composition, Form, and Unique Efficacy

The preparation is provided in the dosage form of a cream, formulated for topical administration and containing a precise 1% concentration of Bifonazole. This cream base is optimized to ensure the active substance is delivered effectively into the skin layers where the fungus proliferates. The unique efficacy of Bifonazole is attributed to its ability to disrupt ergosterol biosynthesis at two separate biochemical points, a mechanism that differentiates it from several other imidazole derivatives. This simultaneous, two-pronged attack results in the compound demonstrating both fungistatic (inhibiting growth) and fungicidal (actively killing) properties, providing a comprehensive strategy for managing the fungal population on the skin. Its fundamental therapeutic purpose is to serve as a broad-spectrum antimycotic to support the effective control and elimination of fungal infections, such as those typically found on the feet or groin.

Advertisements

What side effects are possible with Fungiderm 1%?

Possible side effects and safety information

The officially documented safety profile of Fungiderm 1% (Bifonazole) is structured around adverse reactions primarily localized to the application site. Regulatory classification groups these effects under Skin and Subcutaneous Tissue Disorders.

Frequency-Classified Adverse Reactions

Adverse reactions are classified according to incidence rates documented in official regulatory sources:

Classification Examples of Reactions
Common Pruritus (itching), erythema (redness), irritation, and burning sensation.
Uncommon Contact dermatitis, skin exfoliation (peeling), eczema, and skin oedema (swelling).
Not Known Systemic hypersensitivity reactions and angioedema.

These local effects are typically reversible and tend to subside upon discontinuation of treatment, a pattern noted in regulatory summaries. Serious adverse reactions, such as Systemic Hypersensitivity and Angioedema, are rare reports classified under Immune System Disorders.

Safety Constraints and Population Notes

The medicine is contraindicated in individuals with known hypersensitivity to Bifonazole, excipients, or other imidazole antifungal agents. Specific safety considerations are noted for certain populations in official labeling:

  • Pregnancy: Use is advised to be avoided during the first trimester.
  • Infants: Use in infants and young children requires medical supervision.

Furthermore, official documents note a high-level safety consequence related to concomitant medication: caution is advised for patients taking the anticoagulant Warfarin, as the label requires appropriate monitoring of Prothrombin Time (INR) due to a potential interaction.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Fungiderm 1% (Bifonazole 1% Cream) primarily addresses the specific circumstance of accidental oral ingestion.

Regulatory authorities classify the risk of acute systemic intoxication as unlikely to occur following a single dermal application of an overdose or from inadvertent oral intake. The required emergency protocol is strictly focused on managing the potential consequences of a swallowed dose.


Emergency Actions and Manifestations

When Immediate Medical Help is Required:

If the cream is swallowed accidentally, it is mandatory to seek immediate medical attention. Users must contact the Accident and Emergency Department of the nearest hospital or physician immediately to report the ingestion, regardless of whether symptoms are currently present.

Documented Clinical Manifestations:

Should clinical signs of overdose become apparent following accidental ingestion, the manifestations documented in official labeling include dizziness, nausea, and vomiting.

Officially Described Supportive Measures:

Management is procedural and supportive. Routine measures such as gastric lavage are described in the regulatory information, but this action is strictly conditioned. Gastric lavage should only be performed if the documented clinical symptoms are present and if medical personnel can ensure the patient's airway can be protected adequately. No specific antidote is known or documented in the official prescribing information.

Advertisements

Therapeutic Uses of Fungiderm 1%

The therapeutic application of Fungiderm 1% is used for managing conditions that involve episodic or fluctuating manifestations of common skin mycoses, supporting the patient during difficult episodes by easing distress and relieving associated symptoms. The active ingredient is applied in therapeutic areas involving inflammatory or irritative states caused by a broad spectrum of pathogens.

Fungiderm 1% is commonly applied across conditions presenting with acute episodes of superficial dermatological infections, including those caused by dermatophytes (such as ringworm, athlete's foot, and jock itch) and yeasts (like cutaneous candidiasis and pityriasis versicolor). It is relevant in clinical settings marked by the visible proliferation of these pathogens on the skin's surface. The cream is commonly used to help with the significant symptomatic discomfort, primarily the persistent itching and burning sensation.

Quick Fact: Symptomatic Relief

Property Description
Relief for Itching (pruritus), Burning, Redness (erythema)
Main Benefit Supports easing of overall symptom burden
Use Context Infections in high-risk areas (e.g., skin folds, between toes)

By providing support that helps ease the overall symptom burden, the medication contributes to improved day-to-day comfort during periods of heightened symptoms. The intent is to assist with maintaining functional stability when symptoms interfere with routine activities.

Regulatory References

  1. UK Medicines and Healthcare products Regulatory Agency (MHRA) document
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Fungiderm 1% (Bifonazole 1% Cream)

Official regulatory documents strictly define the populations eligible for Fungiderm 1% use, focusing on contraindications and conditional restrictions. The medicine is contraindicated in any patient with a known hypersensitivity to the active substance, Bifonazole, or to any of the product’s inactive ingredients. Patients with a history of allergy to other imidazole antifungal agents must also use the cream with caution.


Population Restrictions

Population Group Eligibility Status Regulatory Basis
Adults and Adolescents Approved for use under standard labeled conditions. Standard Use
Infants and Toddlers Use is conditional; must be under medical supervision (typically under 3 years). Precautionary Restriction
Pregnancy (1st Trimester) Not recommended or should be avoided. Gestational Precaution
Lactation (Breast Area) Not recommended for application to the chest area. Prevent Infant Ingestion
Renal/Hepatic Impairment No specific restrictions documented. Low Systemic Absorption

Use is generally permitted for adults and adolescents. However, due to its topical route and minimal systemic absorption, the official labeling documents no restrictions based on major systemic conditions like renal or hepatic impairment. The eligibility profile is strictly focused on patient history of allergy and heightened caution during specific life stages.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information addresses interactions primarily based on the drug's limited systemic absorption and its specific method of administration.

Pharmacokinetic and Systemic Interactions

Due to the minimal absorption of the 1% topical formulation into the bloodstream, the risk of systemic pharmacokinetic interactions that affect other orally or injected medicines is considered low. Regulatory documents do not typically specify major systemic interactions for the topical product.

However, some regulatory summaries have noted a need for caution when co-administered with Trimetrexate, suggesting a possible requirement for dose modification or precautions for the latter medicine, based on data derived from official drug information summaries.

Local and Administration-Related Interactions

Specific local constraints are documented concerning the use of the intravaginal preparation:

  • Contraceptive Devices: The intravaginal form of this product may physically damage latex or rubber contraceptive devices, such as condoms and diaphragms. Use of these devices may lead to contraceptive failure, and patients are advised against relying on them during treatment and for a period immediately following.
  • Other Antifungals: Studies documented in regulatory files have indicated that co-administration with other antifungal agents, specifically Nystatin, Amphotericin B, or Flucytosine, does not result in an antagonistic or synergistic effect against C. albicans strains.

These constraints define the interaction profile by focusing on the local product effects rather than systemic drug-drug interactions.

Advertisements

Mechanism of Action

Fungiderm 1% (Bifonazole) exerts its effect through a unique, two-pronged molecular mechanism that disrupts the structural integrity of the fungal cell. The mechanism relies entirely on localized action against specific enzymatic pathways within the pathogen.

Dual Enzyme Blockade in Sterol Production

The mechanism initiates with the inhibition of two different, critical enzymes within the fungal cell's ergosterol biosynthesis pathway: Lanosterol 14alpha-demethylase (CYP51) and HMG-CoA reductase. This unique, dual-point action contributes to a substantial disruption of fungal metabolism. The resulting cascade significantly limits the synthesis of the essential membrane lipid, ergosterol, and promotes the accumulation of toxic sterol precursors.

Fungal Cell Membrane Structural Failure

The depletion of ergosterol and the incorporation of faulty lipids severely compromise the fungal cell membrane's structure and function. This instability leads to a loss of membrane fluidity and permeability, causing intracellular leakage and the fungicidal effect (cell death) against susceptible pathogens.

Modulation of Local Irritation Pathways

In addition to its primary action, Bifonazole demonstrates a secondary, distinct mechanism by modulating localized host-mediated biological responses.

Advertisements

Dosage and Administration Information

Official Administration Guidelines

The usage of Fungiderm 1% (Bifonazole 1% Cream) is defined by standardized methods for topical application.

Instruction Detail
Route of administration Cutaneous use; for external application only.
Dosing schedule Apply a thin layer, gently rubbed into the affected area. A small amount (e.g., pea-sized) is considered sufficient for an area equivalent to the size of the palm of the hand.
Frequency and Timing Applied once daily, preferably in the evening before retiring.
Preparation The affected skin areas must be washed and dried thoroughly prior to each application.
Age-group rules Use on infants and children is recommended only under medical supervision.
Missed-dose rules If an application is missed, it should be applied as soon as remembered; however, if it is almost time for the next scheduled dose, the missed dose should be skipped.
Special conditions The cream must not be applied to the eyes or swallowed.

Course Duration Protocol

The treatment course is governed by the specific fungal infection and must be carried out over the full duration specified to ensure lasting effectiveness, regardless of whether the visible signs of the infection clear before the mandated period ends.

Infection Type (Example Durations) Typical Duration (Weeks)
Tinea pedis (Athlete's Foot) 3 weeks
Tinea corporis, Tinea inguinalis (Ringworm, Jock itch) 2 to 3 weeks
Superficial candidiasis of the skin 2 to 4 weeks

These instructions establish a regimen of dose, frequency, and total duration, adhering to the standardized pharmaceutical protocol for Bifonazole 1% topical preparations.

Advertisements

Recent Clinical Evidence

Fungiderm 1% (Clotrimazole): Recent Clinical Evidence

Fungiderm 1% is a topical antifungal cream containing clotrimazole, an imidazole derivative commonly used for superficial fungal skin infections. Clinical studies have investigated its use across a range of dermatophytes and yeasts.


Efficacy in Common Tinea Infections

Clinical trials, including randomized, controlled studies, have evaluated the 1% clotrimazole formulation for the treatment of common fungal skin conditions, such as tinea pedis (athlete’s foot), tinea cruris (jock itch), and tinea corporis (ringworm). Study outcomes often measure mycological cure (elimination of the fungus) and clinical cure (resolution of symptoms like itching and redness).

  • Tinea Pedis: One comparative, double-blind study examining the efficacy of 1% clotrimazole cream, applied topically, reported high rates of mycological cure, demonstrating results similar to other established topical antifungal agents.
  • Comparative Trials: Systematic reviews have noted that while azoles (the class to which clotrimazole belongs) show superior efficacy compared to a placebo for tinea pedis, studies comparing different topical antifungal classes often yield mixed results regarding consistent superiority.

Safety Profile and Tolerability

Topical 1% clotrimazole is generally considered well-tolerated in clinical use and in trials. Adverse reactions reported are typically mild, temporary, and limited to the site of application.

Common Local Adverse Events in Studies
Burning sensation
Local irritation/itching
Redness (erythema)

Serious adverse effects, such as hypersensitivity reactions, are rare. Because absorption through intact skin is minimal, the risk of systemic side effects is low when the medication is used as directed.

Key Studies & References

  1. Clotrimazole Topical Monograph for Professionals (Clinical Indications, Safety, and Pharmacokinetics)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Fungiderm 1% (FAQ)


Q: Is Fungiderm 1% available without a prescription?

In many jurisdictions, the official licensing status of Fungiderm 1% (Bifonazole) is categorized as an Over-The-Counter (OTC) or Non-Prescription medicine. This status, defined in regulatory documents, allows the product to be made available for purchase without a doctor’s prescription.


Q: Does Fungiderm 1% contain steroids?

According to the official product information and composition listing, Fungiderm 1% is composed solely of the active antifungal ingredient Bifonazole. It does not contain any corticosteroid (steroid) agents.


Q: What is the meaning of the '1%' concentration in Fungiderm 1%?

The 1% concentration is a technical description defined in the official regulatory composition of the cream. It indicates that the product is formulated to contain 1 gram of the active substance, Bifonazole, per 100 grams of the total product weight.


Q: What is the difference between Fungiderm 1% and a topical steroid cream?

Fungiderm 1% is classified as an azole antifungal derivative intended to eliminate fungi from the skin. In contrast, topical steroid creams belong to the corticosteroid class, which is primarily used to reduce inflammation. Official sources classify these as two distinct pharmacological categories.


Q: What should I do if the cream causes a mild burning sensation?

Official regulatory documents describe a burning sensation as a common, expected local reaction at the application site. The effect is documented as typically reversible, often subsiding after the product is stopped.


Q: Does Fungiderm 1% have an expiration date I should look out for?

Regulatory storage and safety information mandates that the product should not be used past the expiration date printed on the tube and/or carton. Using the product within this period supports maintaining its quality and stability.


Q: Is Fungiderm 1% effective against all types of fungus?

Official pharmacological classifications describe Fungiderm 1% as a broad-spectrum antimycotic. Studies indicate it has documented activity against a range of susceptible pathogens, including dermatophytes, yeasts, and moulds, which are common causes of skin infections.


Q: Do I need to wash my hands immediately after applying Fungiderm 1%?

Official administration instructions emphasize applying the cream to clean, dry skin. General product information notes that washing hands after application may help prevent unintended transfer of the medication to sensitive areas, such as the eyes.


Q: What happens if a small amount of Fungiderm 1% is accidentally swallowed?

The cream is strictly intended for external use, and regulatory documents advise against ingestion. If accidental swallowing of a large amount occurs, official guidance notes that contact with emergency medical services or a poison control center is appropriate for such events.


Q: Can I use Fungiderm 1% if I have a pre-existing skin condition like eczema?

Regulatory documentation lists eczema as an uncommon local skin reaction that has been reported during product use. Official product information, however, does not contain specific guidance or restrictions regarding its use on skin where eczema is pre-existing.


Q: Can Fungiderm 1% be used for skin issues other than fungal infections?

The therapeutic indications for Fungiderm 1% are strictly defined in official documents for the management of fungal skin infections. Its effectiveness is limited to infections caused by pathogens susceptible to the active ingredient, Bifonazole.


Q: Is Fungiderm 1% the same as other 'azole' creams?

While Fungiderm (Bifonazole) is chemically an azole, official regulatory summaries note a distinction in its mechanism of action. Bifonazole utilizes a dual point of inhibition in the fungal cell's sterol pathway, differing from many other azoles that feature only a single point of inhibition.


Q: How quickly do most people notice a change after starting Fungiderm 1%?

The official duration of treatment is defined by the type of infection (e.g., 2–4 weeks), which is the period determined necessary to achieve mycological cure (elimination of the fungus). This defined course of use reflects the time needed for the medication to achieve this result.


Q: Does Fungiderm 1% interact with common pain relievers?

Regulatory documents indicate that due to the minimal systemic absorption of the topical cream, the risk of clinically relevant systemic drug-drug interactions is considered unlikely. This includes interactions with orally administered medicines such as common pain relievers.


Q: Can Fungiderm 1% cause skin discoloration?

Skin discoloration is not explicitly listed as a common or uncommon adverse reaction in the official regulatory documents describing the safety profile of the cream.


Q: Can I use other skin products like lotions while using Fungiderm 1%?

Official product information emphasizes applying the product to clean, dry skin, and spacing out the application of other topical products may help avoid potential dilution of Fungiderm 1% or interference with its effectiveness.


Q: How is the safety of Fungiderm 1% monitored after it is released?

The safety of Fungiderm is continuously monitored through official post-marketing surveillance. This process is documented in regulatory sources and involves the collection of reported suspected adverse reactions from both patients and healthcare professionals.


Q: Are there any known interactions between Fungiderm 1% and alcohol?

Official regulatory summaries, which list known constraints and warnings, do not include any specific interactions or warnings concerning the use of Fungiderm 1% cream with alcohol consumption.


Q: Can I use Fungiderm 1% on my scalp?

Regulatory documentation indicates that its therapeutic use includes conditions such as Tinea capitis (scalp ringworm), supporting its use in that area for indicated infections.


Q: Is Fungiderm 1% safe for use on sensitive skin?

Regulatory documents describe common local skin reactions, such as irritation and redness, that some users experience. However, official labeling does not contain a classification regarding the product’s specific suitability for use on skin defined as 'sensitive'.


Q: Can I apply Fungiderm 1% and then cover the area with a bandage?

The regulatory documents describe the method of administration as applying a thin layer and gently rubbing it in. Official information does not explicitly prohibit or recommend the use of occlusive dressings or bandages with the cream.


Q: Are there long-term side effects associated with Fungiderm 1%?

Studies on the product’s absorption through the skin show that percutaneous absorption is minimal. Based on this, the official regulatory assessment is that the risk of systemic long-term side effects is considered low when the product is used topically for the recommended duration.


Q: Does Fungiderm 1% interact with herbal supplements?

Official regulatory documents specifically state that formal interaction studies have not been conducted with herbal supplements. This means there is currently no official data on any potential interactions between Fungiderm 1% and these products.


Q: Does Fungiderm 1% contain parabens or other preservatives?

The official composition lists the inactive ingredients (excipients) used in the cream’s formulation. These excipients are defined in regulatory documentation and may include preservatives such as Benzyl alcohol.


Q: Does sunlight affect the area treated with Fungiderm 1%?

Official regulatory warnings and precautions are required to list any known concerns regarding phototoxicity or photosensitivity. The product information does not document specific warnings related to sun exposure for the area treated with the cream.


Q: What research exists about using Fungiderm 1% in older adults?

Official studies and regulatory assessments generally indicate that there is no need for specific dose adjustments for the older adult population. This indicates that the product has been assessed for use and is included within the approved population group.

Advertisements

How should Fungiderm 1% be stored and disposed of?

Storage and Disposal Requirements for Fungiderm 1% (Bifonazole)

The storage and handling of Fungiderm 1% cream must adhere to specific regulatory requirements to maintain the product’s quality and stability. The cream must be stored at room temperature, typically defined as below 25 C (77 F), and it is mandatory to not freeze the product.

Required Protection and Security

For stability, the cream must be protected from light and stored away from excess heat and moisture. The container must be kept tightly closed when not in use. For safety, the medicine must always be stored out of the sight and reach of children and away from pets.

Disposal

Fungiderm 1% should not be used past the expiration date. Unused or expired cream must be disposed of according to local regulatory requirements and should not be discarded into household waste or wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fungiderm 1% found in:

A-Z Index: